Dr. Kelly Shepard By Dr. Kelly Shepard We love sharing exciting news about recent discoveries or announcing the launch of a new CIRM-funded clinical trial because they offer tangible signs of progress, but the background work to build a gene and cell therapy "pipeline" is no less important. Behind the scenes Important signs of progress also happen … Continue reading Building a gene and cell therapy pipeline
Jill Helms
Moving Beyond Current CIRM Funding
Delivering on CIRM’s mission of “accelerating stem cell treatments to patients with unmet medical needs” requires the participation of multiple stakeholders to span the research, development, and commercialization phases of bringing a new product to market. In this post, I am pleased to highlight two recent examples of CIRM-funded projects moving beyond their period of … Continue reading Moving Beyond Current CIRM Funding